Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration

dc.contributor.authorKaparakis-Liaskos, Maria
dc.contributor.authorTate, Michelle D.
dc.contributor.authorPrice, Jason D.
dc.contributor.authorPearse, Martin
dc.contributor.authorWijburg, Odilia L. C.
dc.date.accessioned2015-10-28T02:09:36Z
dc.date.available2015-10-28T02:09:36Z
dc.date.issued2013-03-27
dc.date.updated2015-12-10T09:21:30Z
dc.description.abstractCholera toxin (CT) is a mucosal adjuvant capable of inducing strong immune responses to co-administered antigens following oral or intranasal immunization of mice. To date, the direct effect of CT on antigen-specific CD4(+) T cell migration and proliferation profiles in vivo is not well characterized. In this study, the effect of CT on the migration pattern and proliferative responses of adoptively transferred, CD4(+) TCR transgenic T cells in orally or intranasally vaccinated mice, was analyzed by flow cytometry. GFP-expressing or CFSE-labeled OT-II lymphocytes were adoptively transferred to naïve C57BL/6 mice, and mice were subsequently vaccinated with OVA with or without CT via the oral or intranasal route. CT did not alter the migration pattern of antigen-specific T cells, regardless of the route of immunization, but increased the number of transgenic CD4(+) T cells in draining lymphoid tissue. This increase in the number of transgenic CD4(+) T cells was not due to cells undergoing more rounds of cellular division in vivo, suggesting that CT may exert an indirect adjuvant effect on CD4(+) T cells. The findings reported here suggest that CT functions as a mucosal adjuvant by increasing the number of antigen specific CD4(+) T cells independent of their migration pattern or kinetics of cellular division.
dc.description.sponsorshipGrant support was received from the National Health and Medical Research Council of Australia (NHMRC). OLW is a recipient of an R.D. Wright Career Development Award.en_AU
dc.format11 pages
dc.identifier.issn1932-6203en_AU
dc.identifier.urihttp://hdl.handle.net/1885/16148
dc.publisherPublic Library of Science
dc.rights© 2013 Kaparakis-Liaskos et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.sourcePLoS ONE
dc.subjectadministration, intranasal
dc.subjectadministration, oral
dc.subjectanimals
dc.subjectcd4-positive t-lymphocytes
dc.subjectcell division
dc.subjectcell movement
dc.subjectcell proliferation
dc.subjectcholera toxin
dc.subjectdendritic cells
dc.subjectepitopes
dc.subjectevans blue
dc.subjectfluoresceins
dc.subjectgreen fluorescent proteins
dc.subjecthistocompatibility antigens class ii
dc.subjectkinetics
dc.subjectlymphocyte count
dc.subjectmice
dc.subjectmice, inbred c57bl
dc.subjectmice, transgenic
dc.subjectmucous membrane
dc.subjectovalbumin
dc.subjectpeptides
dc.subjectsuccinimides
dc.titleIncreased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration
dc.typeJournal article
dcterms.dateAccepted2013-02-22
local.bibliographicCitation.issue3en_AU
local.bibliographicCitation.startpagee59934en_AU
local.contributor.affiliationKaparakis-Liaskos, Maria, The University of Melbourne, Australiaen_AU
local.contributor.affiliationTate, Michelle D, Monash Institute of Medical Research, Australiaen_AU
local.contributor.affiliationPrice, Jason, Non-ANU institution, Lipotek Pty Ltd, Lipoteken_AU
local.contributor.affiliationPearse, Martin, CSL, Australiaen_AU
local.contributor.affiliationWijburg, Odilia L. C., The University of Melbourne, Australiaen_AU
local.contributor.authoruidu4884728en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor119999en_AU
local.identifier.ariespublicationU3488905xPUB845en_AU
local.identifier.citationvolume8en_AU
local.identifier.doi10.1371/journal.pone.0059934en_AU
local.identifier.essn1932-6203en_AU
local.identifier.scopusID2-s2.0-84875423766
local.publisher.urlhttps://www.plos.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Kaparakis-Liaskos_Increased_antigen_specific_T_2013.pdf
Size:
627.23 KB
Format:
Adobe Portable Document Format
Description:
Published Version

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: